Sonnet Biotherapeutics Pronounces 1-Okay-14 Reverse Inventory Break up

Information and analysis earlier than listening to about it on CNBC and others. Declare Your 1-Week Free Trial StreetInsider Premium Right here. Princeton, NJ /AccessWire/September 16, 2022/ Sonnet Biotherapeutics Holdings, Inc. (NASDAQ: SONN) (“Sonnet” or “The Firm”), a biopharmaceutical firm growing revolutionary focused biologic medication, as we speak introduced that it’s going to impact a … Read more